文献速递免疫规划传染病防控与疫情报告

空斑减少中和试验(PRNT50)检测临床样本中抗黄热病毒抗体

Plaque reduction neutralization test (PRNT50) for the detection of anti-yellow fever antibodies from clinical samples.
PubMed 文献 · Vaccine · 2025-12-23

黄热病在部分南美和非洲地区仍呈地方性流行,虽已有安全有效疫苗超过75年,仍是公共卫生问题。自然感染和疫苗接种均产生中和抗体,但黄病毒属血清学交叉反应给特异性抗体检测带来挑战。本研究开发并验证了内部PRNT50试验,用于测量黄热病毒特异性中和抗体,验证参数包括特异性、线性、精密度、准确度和稳健性。结果显示该试验具有特异性、稳健、精确和准确的特点,适合评估黄热疫苗接种或自然感染后的中和抗体反应。

要点

  • PRNT被视为检测和测量中和抗体的「金标准」试验。
  • 本研究开发并验证了内部PRNT50试验,用于检测黄热病毒特异性中和抗体。
  • 验证参数包括特异性、线性、精密度、准确度和稳健性,结果显示试验合格。

核心结论

  • 内部PRNT50试验被证明具有特异性、稳健、精确和准确的特点,适合评估黄热疫苗接种或自然感染后的中和抗体反应。

研究设计与样本

  • 本研究为诊断试验的开发与验证研究,开发并验证内部PRNT50试验用于测量黄热病毒特异性中和抗体。

主要发现

  • PRNT50试验在特异性、线性、精密度、准确度和稳健性等参数上均显示合格。

关键数值与推荐

  • PRNT被认为是检测和测量中和抗体的「金标准」试验。
  • 验证参数包括特异性、线性、精密度、准确度和稳健性。

临床怎么用

  • 该PRNT50试验可用于评估黄热疫苗接种或自然感染后的中和抗体反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Yellow fever (YF) is a mosquito-borne viral haemorrhagic disease that remains endemic in parts of South America and Africa. Although there is a safe and effective vaccine that has been available for over 75 years, YF remains a public health problem in areas with endemic as well as sporadic transmission. Immune responses elicited by natural infection with yellow fever virus and vaccination are marked by production of neutralizing antibodies. Serological cross-reactivity exhibited by flaviviruses poses challenges to the diagnostic tests for detection of YF-specific antibodies. The most specific plaque reduction neutralization test (PRNT) is considered the "gold standard" test for detecting and measuring the neutralizing antibodies. This study was undertaken to develop and validate in-house PRNT50 test for measurement of YF specific neutralizing antibodies. We validated PRNT50 test using different parameters including specificity, linearity, precision, accuracy and robustness. The YF PRNT50 assay was shown to be specific, robust, precise and accurate. Thus, we have proven suitability of this assay for evaluation of neutralizing antibodies in response to YF vaccination in case of natural infections.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tyagi P, Ganguly M, Manney S, et al. Plaque reduction neutralization test (PRNT50) for the detection of anti-yellow fever antibodies from clinical samples. Vaccine. 2025. PMID: 41442866. doi:10.1016/j.vaccine.2025.128151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。